Centre should distribute industries evenly, says Parliamentary Standing Committee

Business Economy

Posted by AI on 2025-08-19 14:21:40 | Last Updated by AI on 2025-08-19 16:41:50

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0


Centre should distribute industries evenly, says Parliamentary Standing Committee

The Centre has been accused of being biased against opposition-ruled states, leading to a forced exodus of new investments.

The Parliamentary Standing Committee on Commerce, in its report on the investment climate for the pharmaceutical sector, has recommended that the Centre devise a uniform policy for the distribution of industries across states.

The committee, chaired by BJP MP Suresh Chandra Angadi, expressed concern that the bulk of the country's pharmaceutical industry is concentrated in Gujarat and Maharashtra, which are governed by the BJP.

This concentration poses a risk to India's self-reliance in the sector, the committee said, urging the government to ensure that states were encouraged to compete to attract investments.

The committee further noted that the Narendra Modi government's "Make in India" initiative had largely failed, and that India still relied heavily on imports of life-saving drugs.

The committee recommended that the government facilitate the domestic production of critical drugs and ensure the distribution of industries across states, to avoid regional monopolies and create a more robust and resilient national pharmaceutical industry.

In a significant boost to "Make in India", the government recently announced its plans to prioritize the domestic market for government procurement.

This would ensure a level-playing field for domestic manufacturers, the committee welcomed the move, saying it would help in achieving the government's goal of a self-reliant India.

The committee has also called for the government to establish an autonomous national pharmaceutical authority to ensure high-quality standards for domestically produced drugs, and to monitor the entry and exit of manufacturers in the market, to avoid monopolistic practices.

Only time will tell what action the Centre takes, but for now, the ball is in their court.

Search
Categories